Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000769993-25-000289
Filing Date
2025-05-13
Accepted
2025-05-13 11:35:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9378
2 POA13G-20375936_20250505.txt EX-99 5139
  Complete submission text file 0000769993-25-000289.txt   16329
Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET NEW YORK NY 10282 212-902-1000
GOLDMAN SACHS GROUP INC (Filed by) CIK: 0000886982 (see all company filings)

EIN.: 134019460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies
(CF Office: 02 Finance)

Mailing Address 1800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 1800 BRIDGE PARKWAY REDWOOD CITY CA 94065 650-251-0005
NEVRO CORP (Subject) CIK: 0001444380 (see all company filings)

EIN.: 562568057 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-88537 | Film No.: 25938206
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)